TREATMENT RESISTANT PSYCHOSIS

Clinical trials for TREATMENT RESISTANT PSYCHOSIS explained in plain language.

Never miss a new study

Get alerted when new TREATMENT RESISTANT PSYCHOSIS trials appear

Sign up with your email to follow new studies for TREATMENT RESISTANT PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Cannabis compound tested as boost for Toughest-to-Treat psychosis

Disease control Not yet recruiting

This study is testing whether adding a purified cannabis compound called cannabidiol (CBD) can improve the effects of the antipsychotic drug clozapine for people with severe, treatment-resistant psychosis. About 250 participants who haven't responded well to clozapine alone will …

Matched conditions: TREATMENT RESISTANT PSYCHOSIS

Phase: PHASE3 • Sponsor: University of Oxford • Aim: Disease control

Last updated Apr 01, 2026 14:43 UTC

TREATMENT RESISTANT PSYCHOSIS

Get alerted when new TREATMENT RESISTANT PSYCHOSIS trials appear

Cannabis compound tested as boost for Toughest-to-Treat psychosis